Clinical Trial to Assess the Effectiveness of I+Med's DayDrop Advanced Ophthalmic Drop

Inclusion Criteria: * Patients of both sexes over 18 years of age. * Patients diagnosed with mild-moderate dry eye who meet the following characteristics: Schirmer test ≥3 and ≤ 10 mm; BUT test ≥5 and ≤ 10 seconds and OSDI ≥13 and ≤ 33. * Patients without other ophthalmologic pathologies. * Have ability to self-administer drops. * Have ability to understand the Patient Information Sheet. * Sign the Informed Consent. Exclusion Criteria: * Patients diagnosed with severe dry eye. * Ingestion of parasympathomimetic or antipsychotic medications . * Glaucoma. * Previous cataract surgery. * Systemic treatment with corticosteroids or topical treatment with any ophthalmic medication except artificial tears in the week prior to the start of study treatment. * Ocular infection or clinically significant inflammation. * Ocular surgery in the 3 months prior to the study. * Sjögren's syndrome. * Stevens-Johnson syndrome. * History of allergic conjunctivitis. * Pregnancy or planned lactation.